Streetbeat News

Products Services

SNTMF

SenseTime is shifting focus to generative AI, which now accounts for 60% of its revenue, despite challenges like price wars and GPU restrictions. The company is narrowing its losses and showing revenue growth, but investor enthusiasm is waning.

Portfolio Pulse from The Bamboo Works

September 03, 2024 | 12:59 pm

PRAX

Praxis Precision Medicines shares rose after announcing positive topline results from its Phase 2 study of Relutrigine, which showed a 46% reduction in monthly motor seizures during the double-blind period.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:53 pm

VLVLY

Volvo Trucks is set to launch a next-generation heavy-duty electric truck with a range of up to 600 km, marking a significant step in the electrification of heavy trucks. The new model, featuring advanced driveline technology, will be available in 2025.

Portfolio Pulse from Benzinga Neuro

September 03, 2024 | 12:42 pm

TCBP

TC Biopharm (TCBP) has dosed five new patients in its ACHIEVE Phase 2b trial, which is a significant step in their clinical development process.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:41 pm

ANGO

AngioDynamics has received CE Mark approval for its Auryon System in Europe, which is a significant regulatory milestone that could enhance its market presence and sales in the European region.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:37 pm

RKLB

Rocket Lab has announced the launch date for its second dedicated mission for Kinéis, set for September 17, 2024. This mission is part of a series of five Electron launches aimed at deploying a global IoT constellation.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:37 pm

INBS

Intelligent Bio Solutions (INBS) reported a 118% year-over-year increase in the estimated number of employees across its customer base, indicating strong growth and potential increased demand for its products and services.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:36 pm

CVX

Chevron has announced enhancements in oil and natural gas recovery at two of its U.S. facilities. This development is likely to improve production efficiency and output, potentially impacting Chevron's financial performance positively.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:35 pm

STOK

Stoke Therapeutics will present data on zorevunersen, a potential first disease-modifying treatment for Dravet syndrome, at the European Epilepsy Congress. The data from Phase 1/2a and OLE studies show significant seizure reduction and cognitive improvements.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:35 pm

ARCT

Arcturus Therapeutics has received clearance for its Investigational New Drug (IND) application for ARCT-032, a treatment for cystic fibrosis. This development marks a significant step forward in the company's drug development pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:35 pm